Persistent Asset Partners Ltd
Position in INO — Inovio Pharmaceuticals, Inc.
CIK 2056052
HONG KONG, K3
Position in INO
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$0
-$247,365 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
3 quarters on record
Common Shares in INO Over Time
Shares Held
Position Value (USD)
Derivatives in INO
reported options exposure · as of Jun 30, 2026CallValue
$771
CallShares
701
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Persistent Asset Partners Ltd holds $74,585,923 across 142 Biotechnology names. INO ranks #141 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
38,726 | $7,252,604 | |
| 2 | ABVX |
Abivax S.A.
|
44,256 | $5,897,553 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
138,272 | $5,351,125 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
79,933 | $4,573,766 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
112,736 | $4,397,831 | |
| 6 | EWTX |
Edgewise Therapeutics, Inc.
|
69,441 | $2,821,387 | |
| 7 | KOD |
Kodiak Sciences Inc.
|
56,052 | $2,183,785 | |
| 8 | IMCR |
Immunocore Holdings plc
|
65,214 | $2,070,544 |
All Filings in INO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $771 | 701 | Call | Sole | 2026-08-07 | |
| 2026-06-30 | $0 | 0 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $247,365 | 142,164 | Shares | Sole | 2026-05-12 | |
| 2026-03-31 | $330 | 190 | Call | Sole | 2026-05-12 | |
| 2025-12-31 | $247,365 | 142,164 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||